Generic Name: risdiplam
Brand Name: TBC
Manufacturer: Hoffmann La-Roche Ltd.
Therapeutic Area: Spinal muscular atrophy
Indications: For the treatment of spinal muscular atrophy (SMA)
Manufacturer Requested Reimbursement Criteria1: For the treatment of spinal muscular atrophy (SMA)
Submission Type: Initial
NOC Status at Filing: Pre NOC
Project Status: Received
Companion Diagnostics: No
Fee Schedule: Pending
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
|Call for patient/clinician input open||October 22, 2020|
|Call for patient/clinician input closed||December 10, 2020|
|Submission received||November 19, 2020|